newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates

DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027 Cash and securities of $208.6 million at quarter-end provide strong financial runway CARLSBAD, Calif.,